Founded in 1994, Theralase Technologies, Inc. (OTC: TLTFF) designs, develops and manufactures super-pulsed, cold laser technology for a wide range of human, companion animal and equine applications. Theralase is committed to provide cutting-edge pre-clinical and clinical research to remain the most clinically and scientifically supported therapeutic medical laser on the market. The highly trained Theralase team continuously brings its valued customers the most advanced technology on the market, superior customer service, the latest interactive training and the most up to date clinical protocols to accelerate the success of their practice. For more information, visit the company’s website at www.theralase.com